PolyPeptide Group is proud to report double-digit growth for its pipeline projects.
PolyPeptide Group maintained a strong and healthy pipeline that has gained a significant growth in 2020. This growth in Pipeline Projects reflects the growth in peptide therapeutics market and emphasizes the importance of peptides in drug and vaccine development.
Double-digit growth in pipeline projects was driven by a wide variety of development programs including projects related to COVID-19 therapies and vaccines, as well as new projects focused on Oncology, and Cardiovascular & Metabolic Disorders, among others.
As a Global Leader in Peptide API Manufacturing & Development, the PolyPeptide Group is a trusted partner in several peptide-based projects aimed at therapies and vaccines for the COVID-19 pandemic.
The necessary cookies help to make a website usable by enabling basic functions such as page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
Marketing cookies are used to track visitors through websites. The goal is to display ads that are relevant and interesting to the individual user and therefore more valuable to third-party publishers and advertisers.
Statistical cookies help website owners, through the anonymous collection and communication of information, to understand how visitors interact with websites.
Preferences cookies allow a website to retain information that changes the way the site behaves or displays, such as your preferred language or the region in which you are located.